|
Myeloid Neoplasia
Citations 121-130 of 176 total displayed.
|
Past content
(since Jan 2009):
|
Identification of a novel type of ITD mutations located in nonjuxtamembrane domains of the FLT3 tyrosine kinase receptor
- Frank Breitenbuecher, Susanne Schnittger, Rebekka Grundler, Boyka Markova, Birgit Carius, Alexandra Brecht, Justus Duyster, Torsten Haferlach, Christoph Huber, and Thomas Fischer
Blood 2009; 113: 4074-4077.
[Abstract]
[Full text]
[PDF]
Differentiation therapy of leukemia: 3 decades of development
- Daniel Nowak, Daphne Stewart, and H. Phillip Koeffler
Blood 2009; 113: 3655-3665.
[Abstract]
[Full text]
[PDF]
Improved patient survival for acute myeloid leukemia: a population-based study of 9729 patients diagnosed in Sweden between 1973 and 2005
- Åsa Rangert Derolf, Sigurdur Yngvi Kristinsson, Therese M.-L. Andersson, Ola Landgren, Paul W. Dickman, and Magnus Björkholm
Blood 2009; 113: 3666-3672.
[Abstract]
[Full text]
[PDF]
ICSBP-mediated immune protection against BCR-ABL–induced leukemia requires the CCL6 and CCL9 chemokines
- Valentina Nardi, Olaia Naveiras, Mohammad Azam, and George Q. Daley
Blood 2009; 113: 3813-3820.
[Abstract]
[Full text]
[PDF]
Results of high-dose imatinib mesylate in intermediate Sokal risk chronic myeloid leukemia patients in early chronic phase: a phase 2 trial of the GIMEMA CML Working Party
- Fausto Castagnetti, Francesca Palandri, Marilina Amabile, Nicoletta Testoni, Simona Luatti, Simona Soverini, Ilaria Iacobucci, Massimo Breccia, Giovanna Rege Cambrin, Fabio Stagno, Giorgina Specchia, Piero Galieni, Franco Iuliano, Fabrizio Pane, Giuseppe Saglio, Giuliana Alimena, Giovanni Martinelli, Michele Baccarani, Gianantonio Rosti, and for the GIMEMA CML Working Party
Blood 2009; 113: 3428-3434.
[Abstract]
[Full text]
[PDF]
Structure of the AML1-ETO eTAFH domain–HEB peptide complex and its contribution to AML1-ETO activity
- Sangho Park, Wei Chen, Tomasz Cierpicki, Marco Tonelli, Xiongwei Cai, Nancy A. Speck, and John H. Bushweller
Blood 2009; 113: 3558-3567.
[Abstract]
[Full text]
[PDF]
Anchoring of FLT3 in the endoplasmic reticulum alters signaling quality
- Dirk Schmidt-Arras, Sylvia-Annette Böhmer, Sina Koch, Jörg P. Müller, Lutz Blei, Hauke Cornils, Reinhard Bauer, Sridhar Korasikha, Christian Thiede, and Frank-D. Böhmer
Blood 2009; 113: 3568-3576.
[Abstract]
[Full text]
[PDF]
Bone marrow angiogenesis magnetic resonance imaging in patients with acute myeloid leukemia: peak enhancement ratio is an independent predictor for overall survival
- Tiffany Ting-Fang Shih, Hsin-An Hou, Chieh-Yu Liu, Bang-Bin Chen, Jih-Luh Tang, Hsuan-Yu Chen, Shwu-Yuan Wei, Ming Yao, Shang-Yi Huang, Wen-Chien Chou, Szu-Chun Hsu, Woei Tsay, Chih-Wei Yu, Chao-Yu Hsu, Hwei-Fang Tien, and Pan-Chyr Yang
Blood 2009; 113: 3161-3167.
[Abstract]
[Full text]
[PDF]
Functional involvement of RINF, retinoid-inducible nuclear factor (CXXC5), in normal and tumoral human myelopoiesis
- Frédéric Pendino, Eric Nguyen, Inge Jonassen, Bjarte Dysvik, Abdulkader Azouz, Michel Lanotte, Evelyne Ségal-Bendirdjian, and Johan R. Lillehaug
Blood 2009; 113: 3172-3181.
[Abstract]
[Full text]
[PDF]
The NAD biosynthesis inhibitor APO866 has potent antitumor activity against hematologic malignancies
- Aimable Nahimana, Antoine Attinger, Dominique Aubry, Peter Greaney, Christopher Ireson, Annemette V. Thougaard, Jette Tjørnelund, Keith M. Dawson, Marc Dupuis, and Michel A. Duchosal
Blood 2009; 113: 3276-3286.
[Abstract]
[Full text]
[PDF]
|
|
